A groundbreaking study finds that Atogepant, the new migraine prevention drug, offers immediate relief, reducing migraine occurrences right from the first day of use, significantly enhancing life quality for patients. A recently approved migraine prevention drug, atogepant, may start working immediately, according to a study published today (December 23, 2024) in the online edition of [...]from SciTechDaily https://ift.tt/8zt3N7a